Steris PLC

STE: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|ZbLOCK|&Ts<rLOCK|XdlL$BF

Steris Earnings: Healthy Fundamentals Allow for Accelerated Repurchases and More Investment

Steris reported 6% constant-currency organic revenue growth and 11% adjusted EPS growth for the first quarter of fiscal 2027. Management announced a $600 million investment in a new facility in North Carolina and raised expected capital expenditure in 2027 to $450 million (from $375 million).

Sponsor Center